This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Zhuhai United Laboratories Co., Ltd., Zhuhai United Laboratories Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Journey of Chong Su in Guangdong, China
Introduction
Chong Su, an accomplished inventor based in Guangdong, China, has made notable contributions to the field of chemical compounds. With a focus on developing innovative crystal forms, his work has implications for medicine and therapeutic treatments.
Latest Patents
Chong Su holds a patent for the "Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound." This patent outlines a specific crystal form of a 2-methyl-2-propanol and amino-substituted aryl compound, including a method of preparation. The significance of this invention lies in its application in the formulation of medicines aimed at treating related diseases, showcasing the intersection of chemistry and healthcare.
Career Highlights
Chong Su's career is marked by his role at Zhuhai United Laboratories Co., Ltd., where he applies his expertise in various innovative projects. His dedication to advancing chemical applications has resulted in tangible innovations that enhance medicinal formulations, reflecting his commitment to both science and health.
Collaborations
Chong Su has collaborated with talented colleagues like Xiaolin Li and Zhi Luo. Their collective efforts have fostered an environment of innovation and support, allowing them to push the boundaries of their research and development endeavors at their company.
Conclusion
Chong Su's contributions to the field of chemistry and pharmaceuticals underscore the vital role of inventors in driving forward medical advancements. Through his patent and collaborative efforts, he has demonstrated how innovative thinking can lead to impactful solutions in treating diseases and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile